| Risk | Moderately High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 1.29% |
| NAV | ₹9.81 (27 Oct 2020) |
|---|---|
| Fund Started | 03 Aug 2018 |
| Fund Size | ₹268 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Reliance Industries Ltd. | Energy | Equity | 9.9% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 4.4% |
| ICICI Bank Ltd. | Financial | Equity | 4.3% |
| HDFC Bank Ltd. | Financial | Equity | 4.0% |
| Hindustan Unilever Ltd. | FMCG | Equity | 3.9% |
| Procter & Gamble Health Ltd. | Healthcare | Equity | 3.6% |
| MRF Ltd. | Automobile | Equity | 3.4% |
| Oracle Financial Services Software Ltd. | Technology | Equity | 3.1% |
| Tata Consumer Products Ltd. | FMCG | Equity | 3.0% |
| Gujarat Gas Ltd. | Chemicals | Equity | 2.7% |
Tata Value Fund Series 2 Regular Dividend is a Equity Mutual Fund Scheme launched by Tata Mutual Fund. This scheme was made available to investors on 03 Aug 2018. null is the Current Fund Manager of Tata Value Fund Series 2 Regular Dividend fund.The fund currently has an Asset Under Management(AUM) of ₹268 Cr and the Latest NAV as of 27 Oct 2020 is ₹9.81.
The Tata Value Fund Series 2 Regular Dividend is rated Moderately High risk.
The Scheme seeks to provide capital appreciation over the tenure of the fund through a diversified equity portfolio following value investment strategy.